Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-07

Clinical Trial Update: Comparison of Keppra and Clonidine in the Treatment of Tics [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Keppra (levetiracetam) and clonidine for tic disorders including Tourette syndrome; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonidine (clonidine)
  • Keppra (levetiracetam)

Snippet

Sponsor: Harvey S. Singer | Conditions: Tic Disorders, Tourette Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2011-09-07